DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.
In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.
Read more here.